Assyro AI

FDA Orange Book · active-ingredient family

Atenolol; chlorthalidone

Atenolol; chlorthalidone is approved as 1 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:TENORETIC 100 · NDA 018760

1

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
TENORETIC 100RLD×2TWI PHARMSNDA 018760Jun 08, 1984

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
ATENOLOL AND CHLORTHALIDONE×2NOVITIUM PHARMAANDA 215560ABOct 25, 2021
ATENOLOL AND CHLORTHALIDONE×2UNICHEMANDA 213302ABNov 25, 2020
ATENOLOL AND CHLORTHALIDONE×2ZYDUS PHARMSANDA 210028ABMar 08, 2019
ATENOLOL AND CHLORTHALIDONE×2NOSTRUM LABSANDA 074404May 14, 1998
ATENOLOL AND CHLORTHALIDONE×2PLIVAANDA 074107Sep 24, 1997
ATENOLOL AND CHLORTHALIDONE×2AUROBINDO PHARMA USAANDA 074203Oct 31, 1993
ATENOLOL AND CHLORTHALIDONE×2SUN PHARM INDUSTRIESANDA 073582Apr 29, 1993
ATENOLOL AND CHLORTHALIDONE×2WATSON LABSANDA 073665ABJul 02, 1992
ATENOLOL AND CHLORTHALIDONE×2AIPING PHARM INCANDA 072302ABMay 31, 1990

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Atenolol; chlorthalidone — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.